You are here: Industry Insights > vaccines

News List

Touchlight to Supply GMP dbDNA to Support University of Nottingham’s Clinical Study for a Next-Generation Vaccine for Zika Virus Biotech Newswire
August 22, 2024
Touchlight announced the clinical supply of its proprietary dbDNA™ to the University of Nottingham for research and development of a next-generation DNA vaccine targeting the Zika virus.
Touchlight and GSK Sign License Agreement for Use of Enzymatic dbDNA Production Technology for mRNA Manufacturing Biotech Newswire
July 24, 2024
Touchlight announced a license agreement with GSK, a global leader in biopharmaceutical innovation.
The Growth of Vaccines Beyond Infectious Disease Suzanne Elvidge
April 19, 2024
Vaccination for infectious diseases saves two to three million lives a year worldwide, according to the World Health Organization (WHO).
Viroclinics-DDL Changes Name to Cerba Research PharmaSources
March 15, 2024
Viroclinics-DDL proudly announces changing its name to Cerba Research as of the 1st of April 2024.
The Last Ten Shanghai STAR Market Pharmaceutical IPOs David Orchard-Webb
March 16, 2022
The last ten biopharma companies that have IPO’d on the STAR Market (Shanghai Stock Exchange Science and Technology Innovation Board) are focused on oncology, synthetic biology, genomics, HIV & pain management...
Africa Expands Vaccine Manufacturing Capacity Shem Oirere
March 08, 2022
The outbreak of COVID-19 pandemic has revived the drive by governments in Africa to expand local pharmaceutical manufacturing so as to increase access to affordable quality medicines for the continent’s 1.3 billion people.
Demand for High-End COVID-19 Vaccines to Drive Growth of Excipients Market SHEM OIRERE
December 17, 2021
The COVID-19 pandemic has infected 247 million people and killed five million others as of November 01, 2021 the situation still looks grim due to the high infection rates, the prolonged SARS-CoV-2 virus...
Rolling out the vaccines Sarah Harding
March 18, 2021
The UK became the first country to approve the Pfizer/BioNTech vaccine on 2nd December last year, swiftly followed by the US, the EU, and other countries across the world.
With Zero Five-Year Recurrences, the Emerging Tumor Vaccine Brings Hope of Cure PharmaSources/Wang Hong
January 21, 2021
Undoubtedly, vaccines are one of the most significant milestone inventions in mankind’s fight against diseases, and they have also played an essential role in the treatment of cancer.
Global Demand For COVID-19 Products Presents Huge Opportunities for the Biomanufacturing Sector Sarah Harding
November 27, 2020
In 2020, as part of the fight against COVID-19, we have witnessed incredible collaborations between biotech, big pharma, academia and not-for-profit organizations, all working together to develop treatments and vaccines at record speed.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 13 Next page